October/November 2022

Column

Editor's Page

11/15/2022

Winston Wong, PharmD, Editor-in-Chief

Coming off the annual Oncology Clinical Pathways Congress meeting in Boston after 2 years of a virtual meeting, Winston Wong, PharmD, reflects on the past, present, and future of clinical pathways.

Coming off the annual Oncology...

11/15/2022

Journal of Clinical Pathways

Trending From ACCC

Diversify Your Clinical Trials With ASCO-ACCC Resources

11/15/2022

Association of Community Cancer Centers

Association of Community Cancer Cente...

ACCC discusses the Just ASK training program, which encourages research teams to critically assess their practices and brainstorm improvements or additions that they can make to address systemic barriers and advance health equity.

ACCC discusses the Just ASK...

11/15/2022

Journal of Clinical Pathways

Engaging Payers

Engaging Payers in Specialty Care Value-Based Care Models

11/15/2022

Lili Brillstein, MPH

Lili Brillstein, MPH, provides tips and strategies on how to answer the question, “How do you effectively engage with payers to build models for specialty care?”

Lili Brillstein, MPH, provides...

11/15/2022

Journal of Clinical Pathways

PATIENT PERSPECTIVE

A Proposed Taxonomy for Decision Support Tools Based on Person-Centered Shared Decision-Making

11/15/2022

Alan J Balch, PhD, MSc

Rebekah SM Angove, PhD

Kathleen D Gallagher, MPH

The authors discuss the need for a systematic and transparent process for developing and evaluating decision support tools as it relates to their ability to address nonmedical concerns and impact, as well as patient preferences.

The authors discuss the need for...

11/15/2022

Journal of Clinical Pathways

Feature

Research Reports

Measuring Telehealth Quality in Cancer Care: We Don’t Know What We Don’t Know

11/15/2022

David Blaisdell

Tom Valuck, MD, JD

The authors evaluate key quality considerations related to the use of telehealth in oncology in the context of the National Committee for Quality Assurance and the National Quality Forum's recommendations and discuss strategies to enhance...

The authors evaluate key quality...

11/15/2022

Journal of Clinical Pathways

Research Reports

Optimizing Patient-Provider Communication in Patients With Amyloidosis Using a Virtual Platform

11/15/2022

Arabella Sykes, BSc

Sabrina Rebello, MPH

Isabelle Lousada, MA

Kristen Hsu, BSc

Jason Shore, MBA

Vaishali Sanchorawala, MD

Lisa Mendelson, MSN

Adam Sodowick, BA

The authors present a study that aimed to investigate the real-world use of a virtual platform, Amyloidosis Appointment Companion, in improving communication between patients with amyloidosis and their providers.

The authors present a study that...

11/15/2022

Journal of Clinical Pathways

Department

Conference Highlights

Highlights From the 2022 Oncology Clinical Pathways Congress

11/15/2022

Katie Herman and Craig Ostroff

Katie Herman and Craig Ostroff ...

A roundup of presentations from the official annual conference of the Journal of Clinical Pathways, the Oncology Clinical Pathways Congress. This congress spotlights the use and continued expansion of clinical pathways and their effect on...

A roundup of presentations from...

11/15/2022

Journal of Clinical Pathways

Current Issue

June 2024

Volume 10

Issue 3

Current Issue

Issue Archive

Special Reports

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Winston Wong, PharmD

Gordon Kuntz

Robin T Zon, MD, FACP, FASCO

2021 Care Pathways Working Group

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

$Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma$

Special Report

Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma

01/14/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Editorial Correspondence

October/November 2022

Column

Feature

Department

Current Issue

Special Reports

Subscribe

November 2022 Volume 8 Issue 7

Specialties

Events

Year Round Education

HMP Global Products